135 related articles for article (PubMed ID: 36788076)
1. Whole-Genome Sequencing Reveals Mutational Signatures Related to Radiation-Induced Sarcomas and DNA-Damage-Repair Pathways.
Kim E; Han DJ; Kim BH; Yoo J; Kim HJ; Wu HG; Kim KS; Kim HS; Han I; Moon KC; Park JH; Song S; Kim TM; Chang JH
Mod Pathol; 2023 Jan; 36(1):100004. PubMed ID: 36788076
[TBL] [Abstract][Full Text] [Related]
2. Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma.
Lee CL; Mowery YM; Daniel AR; Zhang D; Sibley AB; Delaney JR; Wisdom AJ; Qin X; Wang X; Caraballo I; Gresham J; Luo L; Van Mater D; Owzar K; Kirsch DG
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31112524
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
4. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
Griewank KG; Wiesner T; Murali R; Pischler C; Müller H; Koelsche C; Möller I; Franklin C; Cosgarea I; Sucker A; Schadendorf D; Schaller J; Horn S; Brenn T; Mentzel T
Mod Pathol; 2018 Mar; 31(3):418-428. PubMed ID: 29099504
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
7. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
8. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
10. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract][Full Text] [Related]
11. Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma.
Hu F; Yu Y; Chen JS; Hu H; Scheet P; Huff CD
J Med Genet; 2021 Mar; 58(3):145-153. PubMed ID: 32447321
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of gene mutation profile of adult soft tissue sarcomas using high-throughput sequencing technology].
Xu SF; Wang WW; Chen J; Liu T; Zhang XX; Xu LB; Zhao ZG; Yu SJ; Guo LX
Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):741-745. PubMed ID: 32988156
[No Abstract] [Full Text] [Related]
13. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
[TBL] [Abstract][Full Text] [Related]
14. The spectrum and significance of secondary (co-occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis.
Dermawan JK; Rubin BP
J Pathol; 2023 Aug; 260(5):637-648. PubMed ID: 37345731
[TBL] [Abstract][Full Text] [Related]
15. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
16. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.
Hensley ML; Chavan SS; Solit DB; Murali R; Soslow R; Chiang S; Jungbluth AA; Bandlamudi C; Srinivasan P; Tap WD; Rosenbaum E; Taylor BS; Donoghue MTA; Hyman DM
Clin Cancer Res; 2020 Jul; 26(14):3881-3888. PubMed ID: 32299819
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas.
Je EM; An CH; Yoo NJ; Lee SH
APMIS; 2012 Aug; 120(8):635-9. PubMed ID: 22779686
[TBL] [Abstract][Full Text] [Related]
18. Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas.
Chan SH; Lim WK; Ishak NDB; Li ST; Goh WL; Tan GS; Lim KH; Teo M; Young CNC; Malik S; Tan MH; Teh JYH; Chin FKC; Kesavan S; Selvarajan S; Tan P; Teh BT; Soo KC; Farid M; Quek R; Ngeow J
Sci Rep; 2017 Sep; 7(1):10660. PubMed ID: 28878254
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
20. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
